Mega Genomics Limited (HKG:6667)
Hong Kong · Delayed Price · Currency is HKD
7.06
+0.01 (0.14%)
May 29, 2026, 3:49 PM HKT
Revenue by Segment
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
| 247.15M | 164.23M | - | - | - | | |
Medical Labs & Research Growth | 50.49% | - | - | - | - | | |
Consumer Genetic Testing Services | - | - | 108.38M | 80.56M | 135.47M | | |
Consumer Genetic Testing Services Growth | - | - | 34.54% | -40.53% | -16.23% | | |
Cancer Screening Services | - | - | 42.92M | 65.17M | 100.59M | | |
Cancer Screening Services Growth | - | - | -34.14% | -35.21% | 142.31% | | |
Ancillary Services and Related Products | - | - | - | - | 1.13M | | |
| 247.15M | 164.23M | 151.30M | 145.73M | 237.19M | | |
| 50.49% | 8.54% | 3.82% | -38.56% | 16.71% | | |
Revenue by Geography
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
| 247.15M | 164.23M | 151.30M | 145.73M | 237.19M | | |
| 50.49% | 8.54% | 3.82% | -38.56% | 16.71% | | |
| 247.15M | 164.23M | 151.30M | 145.73M | 237.19M | | |
| 50.49% | 8.54% | 3.82% | -38.56% | 16.71% | | |
Source: S&P Global Market Intelligence.
